Qiming Venture Partners-backed precision proteomics leader Alamar Biosciences debuts on Nasdaq
Qiming Venture Partners led Alamar Biosciences' Series A round in 2020, and continued to back the company in its Series B and C rounds.
@author-1788515151757110
启明创投致力于成为中国优秀技术创业者们的首选投资机构
Qiming Venture Partners led Alamar Biosciences' Series A round in 2020, and continued to back the company in its Series B and C rounds.
The real moat of a scientific product doesn't come from any single breakthrough, but from the feedback, refinement, and repeated iteration that comes from sustained customer use.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
This ranking systematically maps the landscape, growth momentum, and evolutionary trajectory of China's new economy enterprises.
Global leader in innovative tumor immunotherapy
An international innovative biopharmaceutical company focused on the R&D of extrahepatic-targeted small nucleic acid drugs
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
The value of a technology isn't determined on the day it's launched, but on every day thereafter — when it's repeatedly tested, refined, and put to use again and again.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
a leading player in China's disposable endoscope market